Primary Record
Tofacitinib
- In stock
- 6,318 g
- Purity
- 98.9 %
- CAS
- 477600-75-2
Compound Identifiers & Properties
- CAS
- 477600-75-2
- PubChem CID
- 9818231
- SMILES
- CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N
- Canonical SMILES
- CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12
Names & Synonyms
- Tofacitinib
- Tasocitinib
- rac-Tofacitinib
- racemic-Tasocitinib
- Tedalinab
- racemic-tofacitinib
- (3S,4S)-Tofacitinib
- (3S,4R)-Tofacitinib
- Kinome_3438
- (3R,4S)-Tofacitinib
- UNII-4D6Q6HGC7Z
- CHEMBL234085
- SCHEMBL1120705
- CTK8I8331
- 477600-75-2
- BDBM488640
- HMS3244K17
- HMS3244K18
- HMS3244L17
- HMS3656P08
- HMS3741E17
- HMS5081B17
- BCP01795
- BCP14070
- 344418-92-4
- AN-454
- GRC-10693
- MFCD11035919
- STL452943
- US10961228, Example Tofacitinib
- AKOS032960292
- CID9818231
- CP-690550
- PB20522
- PB31511
- SB18653
- SB18654
- SB20005
- CID 9926791
- NCGC00389589-03
- AK-68808
- CP690550
- SY008635
- CP 690550
- DS-004488
- J1.975.762E
- 1092578-47-6
- 1092578-48-7
- 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- Tofacitinib Impurity 34 (Mixture of Diastereomers)
- 1259404-17-5
- 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-
- 1092578-46-5
- 3-((3S,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- 916591-01-0
- 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)--oxo-
- 4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)--oxo-1-piperidinepropanenitrile
- 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-|A-oxo-, (3R,4S)-
- 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-|A-oxo-, (3S,4R)-
- 3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- 3-(4-methyl-3-(methyl (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- 3-(4-methyl-3-(methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- 3-(4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
- 3-[(3S,4S)-4-METHYL-3-[METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]-1-PIPERIDYL]-3-OXO-PROPANENITRILE
- 3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
- 3-[3-[Methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino]-4-methylpiperidino]-3-oxopropionitrile
- 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxo-propanenitrile
- 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
- 3-{(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile
- 3-{4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl}-3-oxopropanenitrile
- 3-{4-METHYL-3-[METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PIPERIDIN-1-YL}-3-OXOPROPANENITRILE